Atara Biotherapeutics, Inc.

ATRA · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$25,030$25,841$92,942$106,084
Short-Term Investments$17,466$25,884$149,877$264,984
Receivables$1,482$34,108$40,221$986
Inventory$10,655$9,706$1,586$0
Other Curr. Assets$10,261$6,330$10,454$12,567
Total Curr. Assets$64,894$101,869$295,080$384,621
Property Plant & Equip (Net)$41,101$58,791$74,322$79,939
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$3,103$4,844$7,018$3,567
Total NC Assets$44,204$63,635$81,340$83,506
Other Assets$0$0$0$0
Total Assets$109,098$165,504$376,420$468,127
Liabilities
Payables$4,367$3,684$6,871$17,368
Short-Term Debt$13,917$12,179$13,640$2,753
Tax Payable$0$0$0$0
Deferred Revenue$95,092$77,833$8,000$40,760
Other Curr. Liab.$21,198$48,530$50,405$44,905
Total Curr. Liab.$134,574$142,226$78,916$105,786
LT Debt$29,914$45,693$58,064$25,518
Deferred Rev, NC$0$37,562$77,000$55,708
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$41,893$39,254$35,800$1,501
Total NC Liab.$71,807$122,509$170,864$82,727
Other Liabilities$0$0$0$0
Cap. Leases$43,831$57,872$71,704$28,271
Total Liabilities$206,381$264,735$249,780$188,513
Equity
Pref Stock$0$0$0$0
Common Stock$1$11$10$9
Retained Earnings-$2,054,553-$1,969,150-$1,693,024-$1,464,722
AOCI$8-$204-$2,067-$368
Other Equity$1,957,261$1,870,112$1,821,721$1,744,695
Total Equity-$97,283-$99,231$126,640$279,614
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$109,098$165,504$376,420$468,127
Net Debt$18,801$32,031-$21,238-$77,813
Atara Biotherapeutics, Inc. (ATRA) Financial Statements & Key Stats | AlphaPilot